Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$89.36 USD

89.36
5,544,714

-0.31 (-0.35%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $89.35 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (148 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing

by Zacks Equity Research

Medtronic (MDT) concluded the recent trading session at $84.57, signifying a +0.76% move from its prior day's close.

Zacks Equity Research

Generative AI Reshapes Healthcare: 3 Stocks in Limelight

by Zacks Equity Research

Stocks like Medtronic (MDT), Stryker (SYK) and NVIDIA (NVDA) are likely to benefit from the rising prospects of Generative AI in healthcare.

Zacks Equity Research

Here's Why You Should Retain Medtronic (MDT) Stock for Now

by Zacks Equity Research

Investors are optimistic about Medtronic's (MDT) expansion in global markets and stable solvency position.

Zacks Equity Research

Medtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know

by Zacks Equity Research

Medtronic (MDT) concluded the recent trading session at $82.38, signifying a -0.42% move from its prior day's close.

Debanjana Dey headshot

3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2024

by Debanjana Dey

Here are some dirt-cheap MedTech value stocks - DVA, GEHC, HOLX - which are expected to provide long-term gains.

Zacks Equity Research

Medtronic (MDT) Up 2.9% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Indrajit Bandyopadhyay headshot

3 MedTech Stocks With Potential to Benefit From AI Boom in 2024

by Indrajit Bandyopadhyay

Investors looking to tap the budding prospects in the lucrative AI market in 2024 can count on Medtronic (MDT), GE HealthCare Technologies (GEHC) and Hologic (HOLX).

Zacks Equity Research

Medtronic (MDT) Expands AI-Driven Care With New Partnership

by Zacks Equity Research

Medtronic's (MDT) expanded collaboration with Cosmo Pharmaceuticals is a strategic step forward in its quest to use AI to improve patient care.

Zacks Equity Research

The Zacks Analyst Blog Highlights Meta Platforms, JPMorgan Chase, Salesforce, Medtronic and PNC Financial

by Zacks Equity Research

Meta Platforms, JPMorgan Chase, Salesforce, Medtronic and PNC Financial are included in this Analyst Blog.

Sheraz Mian headshot

Top Research Reports for Meta Platforms, JPMorgan Chase & Salesforce

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), JPMorgan Chase & Co. (JPM) and Salesforce, Inc. (CRM).

Zacks Equity Research

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

by Zacks Equity Research

Sector ETF report for IHI

Zacks Equity Research

Company News for Nov 22, 2023

by Zacks Equity Research

Companies in The News Are: CNC, LOW, MDT, BIDU

Zacks Equity Research

Medtronic (MDT) Q2 Earnings Beat Estimates, 2024 View Up

by Zacks Equity Research

Medtronic (MDT) Q2 results reflect broad strength across businesses and geographies, benefiting from durable fundamentals.

Zacks Equity Research

Medtronic (MDT) Reports Q2 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended October 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Medtronic's (MDT) Symplicity Spyral RDN System Gets FDA Boost

by Zacks Equity Research

Medtronic (MDT) receives the FDA approval for Symplicity blood pressure procedure for the treatment of hypertension.

Zacks Equity Research

Why Medtronic (MDT) Could Beat Earnings Estimates Again

by Zacks Equity Research

Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

What's in the Cards for Medtronic (MDT) in Q2 Earnings?

by Zacks Equity Research

Strength in all four businesses is likely to drive Medtronic's (MDT) fiscal second-quarter performance.

Zacks Equity Research

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

by Zacks Equity Research

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks Equity Research

Unlocking Q2 Potential of Medtronic (MDT): Exploring Wall Street Estimates for Key Metrics

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2023.

Zacks Equity Research

Medtronic (MDT) Ascends While Market Falls: Some Facts to Note

by Zacks Equity Research

Medtronic (MDT) closed the most recent trading day at $72.08, moving +1.98% from the previous trading session.

Zacks Equity Research

Medtronic (MDT) Stock Sinks As Market Gains: Here's Why

by Zacks Equity Research

Medtronic (MDT) concluded the recent trading session at $72.48, signifying a -1.28% move from its prior day's close.

Zacks Equity Research

Medtronic (MDT) Outperforms Broader Market: What You Need to Know

by Zacks Equity Research

Medtronic (MDT) reachead $73.42 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close.

Zacks Equity Research

Medtronic (MDT) Laps the Stock Market: Here's Why

by Zacks Equity Research

Medtronic (MDT) closed the most recent trading day at $70.56, moving +0.84% from the previous trading session.

Zacks Equity Research

Medtronic (MDT) Advances But Underperforms Market: Key Facts

by Zacks Equity Research

Medtronic (MDT) closed at $69.97 in the latest trading session, marking a +0.78% move from the prior day.

Zacks Equity Research

The Zacks Analyst Blog Highlights Netflix, Honeywell, RTX, Medtronic and Eaton

by Zacks Equity Research

Netflix, Honeywell, RTX, Medtronic and Eaton are included in this Analyst Blog.